Investing Profile

Paul Sekhri

InvestorVC
President and CEO at eGenesis, Inc. Full-time
aditumbio.comNew York, New York
Photo of Paul Sekhri, eGenesis, Inc. Full-time

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
University of Maryland Network
56 CONNECTIONS
University of Maryland Network
56 CONNECTIONS
University of Maryland College Park Network
37 CONNECTIONS
cb
$100K - $5.0M
$1.5M
2
CompanyStageDateRound SizeTotal Raised
PatientSafe Solutions
Series CSep 2013$7M
$52M
Co-investors: Douglas Carlisle
moksha8 Pharmaceuticals
Series AJun 2008$39M
$39M
Board Member Veeva SystemsPresent
Chairman of the Board Pharming Group N.V.Present
Chair of the Board of Directors CompugenPresent
Chairman Of The Board Compugen Ltd.Present
Board Director IpsenPresent
Board Member eGenesisPresent
Chairman Of The Board Of Directors Longboard PharmaceuticalsPresent
Board Member Spring SciencePresent
Board Member Oryn TherapeuticsPresent
Board Member AdhereTechPresent
Chair of the Board of Directors Resolution TherapeuticsPresent
Member Board of Directors KayotheraPresent
President and CEO eGenesisPresent
President and CEO eGenesis, Inc. Full-timePresent
Chair, President and CEO, vTv Therapeutics, Inc. vTv TherapeuticsPresent
University of Maryland College Park B.Sc. Zoology
University of Maryland B.Sc. Zoology
University of Maryland Bachelor's degree Zoology/Animal Biology